Samsung Medical Center (SMC) is the first healthcare provider in the world to receive Stage 7 of the HIMSS digital imaging adoption model (DIAM) maturity model. INFINITT Healthcare Solutions are currently being used at SMC and were demonstrated in clinical settings during the onsite stage 7 validation including digital pathology, clinical information in cardiology, and Smart ENDO (endoscopy)
News | Enterprise Imaging
Infinitt Healthcare Solutions Plays a Part in HIMSS DIAM Stage 7 Accreditation for First- in -the -World Medical Center

April 10, 2023 — Samsung Medical Center (SMC) is the first healthcare provider in the world to receive Stage 7 of the ...

Home April 10, 2023
Home
The survey reflects the opinions of healthcare cybersecurity professionals that are responsible for either day-to-day operations or oversight of healthcare cybersecurity programs
News | Cybersecurity | By Melinda Taschetta-Millane
2022 HIMSS Healthcare Cybersecurity Survey Report Results Published

April 10, 2023 — The 2022 HIMSS Healthcare Cybersecurity Survey results were recently published. The survey reflects the ...

Home April 10, 2023
Home
Innovative online education platform helping global healthcare professionals address non-communicable diseases
News | Cardiovascular Education
NCD Academy Launches New Health Equity and Social Determinants of Health Course

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

Home April 10, 2023
Home
Studies show up to 8% of individuals will develop an aortic aneurysm during their lifetime, higher than rates of colon and lung cancer combined, and over 80% of ruptured aortic aneurysms cause sudden death
News | Artificial Intelligence
Ochsner Health Announces New Aortic Center; Subscribes to Cutting-Edge Imaging with Cydar Technology

April 6, 2023 — Global death rates from aortic diseases have steadily increased over the past two decades. Studies show ...

Home April 06, 2023
Home
GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak Cardiac Transport System was associated with improved outcomes as compared to the use of traditional cold storage in LVAD patients undergoing Heart Transplantation
News | Heart Failure
Latest Clinical Evidence Points to Paragonix SherpaPak as a Tool to Reduce Unpredictable, Severe Complications following Heart Transplantation

April 6, 2023 — Paragonix Technologies, Inc., a leading organ transplant company, announces new research from a multi ...

Home April 06, 2023
Home
Working with researchers from America’s top institutions, Dr. Peter Kowey is senior author of a study assessing treatment for a condition linked to high stroke risk
News | Atrial Fibrillation
Ablation is Safe and Effective in Treating Atrial Fibrillation, Research Guided by Main Line Health Expert Shows

April 6, 2023 — Atrial fibrillation (AFib) not only causes shortness of breath and palpitations but puts patients at ...

Home April 06, 2023
Home
TeleRay receives ECG data from the source ECG machine, bedside monitor, or other acquisition device as data files in that device's native data format.
News | ECG
TeleRay Announces ECG Results into DICOM and EMR

April 5, 2023 — Sharing, viewing and storing ECG data into PACS and EMR systems has been a struggle for may institutions ...

Home April 05, 2023
Home
Published in Nature, new research from the Smidt Heart Institute shows whether artificial intelligence or sonographers provide most accurate heart evaluations
News | Artificial Intelligence
Is Artificial Intelligence Better at Assessing Heart Health?

April 5, 2023 — Who can assess and diagnose cardiac function best after reading an echocardiogram: artificial ...

Home April 05, 2023
Home
Published in Nature, new research from the Smidt Heart Institute shows whether artificial intelligence or sonographers provide most accurate heart evaluations
News | Cardiovascular Clinical Studies
Study published in Heart strengthens diagnostic value of Acarix CADScor System

April 5, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced the release of a new study ...

Home April 05, 2023
Home
54-year-old with mild chest pain for 3 days who underwent CTPA to assess acute PE
News | Artificial Intelligence
AI Cuts CT Turnaround, Wait Times for Positive Pulmonary Embolus

April 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a ...

Home April 05, 2023
Home
MRI Care Pathway can increase flexibility and efficiency with new tools developed to streamline workflow
News | Magnetic Resonance Imaging (MRI)
New Technology Simplifies MRI Screening for Patients with Cardiac Devices

April 4, 2023 — Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of ...

Home April 04, 2023
Home
Part-time degree format will provide vital skills for career advancement in cardiac device interventional technologies
News | Cardiovascular Education
Harding University Introduces New Professional Pathway Tailored to Cardiac Professionals for its Master of Science in Cardiac Function and Interventional Technology

April 4, 2023 — Harding University has announced it will offer a new degree format for its Master of Science in cardiac ...

Home April 04, 2023
Home
TUM team develops first heart organoid containing cardiac muscle cells and outer layer of the heart wall
News | Artificial Heart
A Mini-Heart in a Petri Dish

April 4, 2023 — A team at the Technical University of Munich (TUM) has induced stem cells to emulate the development of ...

Home April 04, 2023
Home
North America to account for larger share in atrial fibrillation market during 2022–2028; growth driven by rising geriatric population, increasing occurrence of cardiovascular diseases, high accessibility to advanced technologies, growing development of innovative and technologically advanced products, and increasing healthcare expenditure
Feature | Atrial Fibrillation
Atrial Fibrillation Market Reaches $20.92B, According to New Report

According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by ...

Home April 04, 2023
Home
The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Association’s Hypertension journal.
News | Hypertension
Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

April 4, 2023 — The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood ...

Home April 04, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now